Search hospitals > Texas > Houston
Lyndon Baines Johnson General Hospital
Claim this profileHouston, Texas 77026
Global Leader in Cancer
Global Leader in Adenocarcinoma
Conducts research for Recurrence
Conducts research for Breast Cancer
Conducts research for Endometrioid Carcinoma
102 reported clinical trials
15 medical researchers
Summary
Lyndon Baines Johnson General Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Cancer, Adenocarcinoma, Recurrence, Breast Cancer, Endometrioid Carcinoma and other specialties. Lyndon Baines Johnson General Hospital is involved with conducting 102 clinical trials across 222 conditions. There are 15 research doctors associated with this hospital, such as Aung Naing, MD, Shannon Westin, MD, Michael J Overman, MD, and Vicente Valero, MD.Area of expertise
1Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Adenocarcinoma
Global LeaderStage IV
Stage III
Stage II
Top PIs
Aung Naing, MDMD Anderson Cancer Center1 year of reported clinical research
Expert in Tumors
Expert in Solid Tumors
22 reported clinical trials
43 drugs studied
Shannon Westin, MDM D Anderson Cancer Center5 years of reported clinical research
Expert in Ovarian Cancer
Studies Endometrial Cancer
19 reported clinical trials
35 drugs studied
Michael J Overman, MDM D Anderson Cancer Center4 years of reported clinical research
Studies Solid Tumors
Studies Colorectal Cancer
10 reported clinical trials
20 drugs studied
Vicente Valero, MDM D Anderson Cancer Center1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
21 drugs studied
Clinical Trials running at Lyndon Baines Johnson General Hospital
Breast Cancer
Prostate Cancer
Fallopian Tube Cancer
Ovarian Cancer
Colorectal Cancer
Endometrial Adenocarcinoma
Rectal Cancer
Peritoneal Cancer
Recurrence
Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
T-DM1 + Tucatinib
for Breast Cancer
This study is evaluating whether a combination of two drugs may help prevent breast cancer from coming back.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Lyndon Baines Johnson General Hospital?
Lyndon Baines Johnson General Hospital is a medical facility located in Houston, Texas. This center is recognized for care of Cancer, Adenocarcinoma, Recurrence, Breast Cancer, Endometrioid Carcinoma and other specialties. Lyndon Baines Johnson General Hospital is involved with conducting 102 clinical trials across 222 conditions. There are 15 research doctors associated with this hospital, such as Aung Naing, MD, Shannon Westin, MD, Michael J Overman, MD, and Vicente Valero, MD.